Krilogy Financial LLC Has $1.41 Million Holdings in SPDR S&P Biotech ETF $XBI

Krilogy Financial LLC cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 83.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,391 shares of the exchange traded fund’s stock after selling 50,716 shares during the period. Krilogy Financial LLC’s holdings in SPDR S&P Biotech ETF were worth $1,408,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. AQR Capital Management LLC increased its holdings in shares of SPDR S&P Biotech ETF by 77.1% in the first quarter. AQR Capital Management LLC now owns 4,978 shares of the exchange traded fund’s stock valued at $404,000 after purchasing an additional 2,167 shares in the last quarter. Marshall Wace LLP lifted its holdings in SPDR S&P Biotech ETF by 102.3% during the 2nd quarter. Marshall Wace LLP now owns 4,023 shares of the exchange traded fund’s stock worth $334,000 after buying an additional 179,029 shares in the last quarter. The Manufacturers Life Insurance Company acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $260,000. Ameriprise Financial Inc. boosted its position in SPDR S&P Biotech ETF by 123.0% in the 2nd quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after buying an additional 481,408 shares during the last quarter. Finally, EP Wealth Advisors LLC boosted its position in SPDR S&P Biotech ETF by 3.7% in the 2nd quarter. EP Wealth Advisors LLC now owns 5,379 shares of the exchange traded fund’s stock valued at $446,000 after buying an additional 193 shares during the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $151.59 on Friday. The stock has a fifty day moving average of $134.86 and a 200-day moving average of $128.51. The stock has a market capitalization of $9.67 billion, a P/E ratio of 11.47 and a beta of 0.85. SPDR S&P Biotech ETF has a 52 week low of $82.04 and a 52 week high of $154.70.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.